Taking an inquirer-centric approach to rare disease medical information
By Marcelo Vaz, Vice President of Medical Services at [...]
The importance of incorporating decentralised clinical trials (DCTS) and patient centricity by design in rare disease studies
By Marcelo Vaz, Vice President of Medical Services at [...]
Navigating the complexity of compliance review of UK/EU product communications for rare diseases
By Marcelo Vaz, Vice President of Medical Services at [...]
